← FDA DRUG APPROVALS

FDA NDA · NDA018245

SYNTOCINON

Sponsor: NOVARTIS

APPLICATION
NDA018245
TYPE
NDA
ORIGINAL APPROVAL
1980-04-17
LATEST ACTION
1997-05-13
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

SYNTOCINONDiscontinued
OXYTOCIN 10USP UNITS/ML · INJECTABLE · INJECTION

Approval history

1997-05-13Manufacturing (CMC) · Supplement 21 · standardAP
1997-05-02Manufacturing (CMC) · Supplement 20 · standardAP
1997-04-29Labeling · Supplement 22 · standardAP
1994-11-14Labeling · Supplement 19 · standardAP
1993-01-21Labeling · Supplement 18AP
1992-06-08Manufacturing (CMC) · Supplement 17 · standardAP
1989-10-20Manufacturing (CMC) · Supplement 16 · standardAP
1986-09-24Manufacturing (CMC) · Supplement 10 · standardAP
1986-02-04Manufacturing (CMC) · Supplement 8 · standardAP
1984-08-16Manufacturing (CMC) · Supplement 7 · standardAP
1984-08-06Labeling · Supplement 6AP
1984-06-07Labeling · Supplement 9 · standardAP
1983-12-07Manufacturing (CMC) · Supplement 4 · standardAP
1981-01-28Manufacturing (CMC) · Supplement 3 · standardAP
1980-07-18Manufacturing (CMC) · Supplement 2 · standardAP
1980-06-09Manufacturing (CMC) · Supplement 1 · standardAP
1980-04-17Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →